A Mobile App for Medication Adherence in Persons With Hypertension: a Pilot Study
NCT ID: NCT06228417
Last Updated: 2024-03-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
14 participants
OBSERVATIONAL
2020-02-23
2021-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
iMedA: Improving MEDication Adherence Through Person-Centered Care and Adaptive Interventions
NCT04413500
Mobile Technology for Blood Pressure Management
NCT04841317
Mobile Phone in Hypertension Management
NCT01510301
Improving Medication Adherence in Hypertensive Patients
NCT01826435
Optimizing the Approach of Mobile Application Use to Improve Medication Adherence in Patients With Hypertension
NCT04066010
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Adaptive digital intervention
Participants received reminder for medication intake on daily basis. Also, short message regarding hypertension, medication and lifestyle changes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* have hypertension (i.e., ICD 10 codes I10-I15 in the person's medical history) for ≥1 year
* have been prescribed medications to treat said hypertension
* speak and understand Swedish
* have a smartphone
Exclusion Criteria
* previous stroke
* previous myocardial infarction
* psychological disorder or cognitive impairment (i.e. ICD 10 codes F01-F99)
* pregnancy-induced hypertension´
* insulin treatment
* kidney disease, defined as glomerulus filtration rate (GFR) \<60 ml/min.
40 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vinnova
OTHER_GOV
Halmstad University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Slawomir Nowaczyk
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Slawomir Nowaczyk, Professor
Role: PRINCIPAL_INVESTIGATOR
Halmstad University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Halmstad University
Halmstad, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017_04617
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.